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Summary 
Human bone marrow (BM) is a relevant site for immunoglobulin (Ig) generation in vivo. The 
occurrence of BM cells capable of spontaneous and high rate Ig secretion for 14 d in vitro has 
been described previously. Accordingly, these cells provide a suitable model for studying terminal 
B cell maturation within the BM. We have reported recently that these BM cells are not totally 
differentiated when isolated from the body, as they require inductive signals from adherent stromal 
BM cells to complete their maturation. Interleukin (IL)-6 produced by these adherent BM cells 
was identified as one such signal. The present work shows that II.-6 was necessary,  but not suf~cient, 
for the induction of BM Ig-secreting cells, since the cytokine was unable to restore missing IgG 
in nonadherent BM cell cultures. Supernatants (SN) obtained from cultures of stromal adherent 
BM cells, either freshly isolated or derived from long-term BM culture (LTBMC), restored Ig 
secretion by nonadherent BM cells, suggesting that additional soluble factors from BM stromal 
cells were required. Fibronectin (FN) was identified as that factor, as can be deduced from the 
following findings: (a) stromal, but not nonadherent, BM cells constitutively produced FN; 
(b) anti-FN antibodies markedly reduced the IgG secretion in cultures of BM mononuclear cells 
(BMMC), and blocked the inductive effect of stromal cell SN on nonadherent BM cells, and 
such a blockade could be reversed by exogenous FN; and (c) finally, although neither IL-6 nor 
FN alone exerted any effect, the combination of both factors induced optimal Ig secretion by 
nonadherent BM cells. Furthermore, VLA-4 molecules seemed to be the FN receptor that was 
active in this culture system, as indicated by: (a) BM Ig-secreting cells exhibited the phenotype 
VLA-4 + VLA-5-; (b) mAbs directed to VLA-4 (anti-CD29 and anti-CD49d), but not those 
directed to other adhesion molecules, inhibited Ig secretion by BMMC cultures, and this effect 
was reversed by FN;  (c) the inductive role of the entire FN molecule could be replaced by a 
fragment containing the CS-1 region, but not by a fragment containing the RGDS sequence; 
and (d) only mAbs anti-CD49d capable of blocking VLA-4-FN interaction inhibited induction 
by either the FN or the CS-l-containing fragment of FN. These results suggest that, in addition 
to II~6, the interaction of FN produced by stromal BM cells with VLA-4 molecules present 
on the surface of BM producers is critical for the latter cells to differentiate into the prolonged 
and high rate Ig-secreting stage characteristic  of these cells. Therefore, cells from the marrow 
microenvironment might contribute to the terminal maturation of Ig-secreting BM cells in vivo. 
I 
n adult life, the mammalian bone marrow (BM) 1 is the 
main reservoir  for high rate Ig-secreting B lymphocytes 
(1, 2). The origin of these cells has not been fully clarified. 
At least in part, they appear to be generated in distant lym- 
1 Abbreviations used in thisHtx,  v: BM, bone marrow; BMMC, bone marrow 
mononuclear cells; Cx, cycioheximide; ECM, extracellular matrix; FN, 
fibronectin; LTBMC, long-term BM culture; MPA, mycophenolic acid; 
OH-U, hydroxyurea; SN, supernatant. 
phoid tissues upon exposure to antigens, and, after a short 
period of maturation, migrate into the BM in a "pro-plasma 
cell" state (3-6).  Accordingly,  the BM becomes an impor- 
tant site for antibody and serum Ig formation (1, 2). 
BM B cells capable of spontaneous and high rate Ig secre- 
tion in vitro have been described in several species (5, 7). In 
humans, cells of this kind are present at low frequencies 
(10-3-10 -4 in BM mononuclear cell [BMMC]  fractions), 
and still produce considerable  quantities of Ig (10  s mole- 
cules/cell per hour) over a period of 14 d without requiring 
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nonproliferating cells  that exhibit the phenotype CD20- 
CD19 •  CD38 + (7-9).  Furthermore, the presence  of these 
cells has been dearly connected with in vivo-induced anti- 
body responses (10, 11), and there is evidence suggesting that 
they could account for most of serum Ig generation (8). Al- 
together, these features indicate that human BM spontaneous 
Ig-secreting cells have reached an advanced stage of matura- 
tion in vivo. As such, they appear particularly adequate for 
analyzing the regulation of terminal B  cell differentiation 
within the BM. 
In a previous report (12), we have shown that these calls 
are not totally differentiated, when isolated from the body. 
Adherent BM stromal ceils, either freshly isolated or derived 
from long-term BM culture (LTBMC), provided the anx- 
iliary signals necessary for these BM B calls to proceed into 
the high rate and prolonged Ig-secreting stage. II.r6 produc- 
tion by BM stromal cells seems to be essential in this process. 
The present study shows that ID6 is necessary but not 
suffldent for the terminal maturation of BM Ig-secreting cells, 
since an additional factor produced by BM stromal ceils is 
required. This factor was found to be the well-known com- 
ponent of the serum and of the extracellular matrix (ECM) 
fibronectin (FN). Additionally, VLA-4 molecules are shown 
to be present on the surface of the BM Ig-secreting cells, and 
to function as FN receptors on such calls. These results indi- 
cate that VLA-4-FN interaction plays a relevant role in the 
differentiation of human BM cells capable  of high rate Ig 
secretion. 
Materials  and Methods 
Materia/s.  Hydroxyurea (OH-U) and cycloheximide  (Cx) were 
purchased from Calbiochem Corp. (San  Diego, CA). Purified and 
PE-conjugated OKT10 (CD38) mAb was obtained from Ortho 
Diagnostic Systems (Raritan, NJ). Rabbit anti-human FN anti- 
body was provided by Dako Corp. (Glostrup, Denmark). Anti- 
human FN mAb and Insulin-Transferrin-Sodinm  Selenite Supple- 
meat used in serum-fxee  cultures were from Boehringer Mannheim 
(Mannheim, Germany). Goat anti-human IgG and peroxidase- 
conjugated goat F(ab')a anti-human IgG used in the ELISA sand- 
wich for IgG detection, and peroxidase-conjugated goat F(ab~ 
anti-rabbit  IgG used in the sandwich ELISA for FN were from 
Tago Inc. (Burlingame, CA). FITC-conjugated goat F(ab')z anti- 
human Ig and anti-mouse  I8  G used in direct and indirect im- 
munofluoresceace procedures,  respectively, were provided by 
Kallestad  Diagnostics  (Austin, TX). Magnetizable  beads conjugated 
with goat anti-mouse Ig antibodies and the magnetic particle con- 
ceatrator (MPC  ~  1) used in cellular selection techniques were ob- 
tained from Dynal (Oslo, Norway). M24-AK Dynatech microtiter 
plates were used in the ELISA test for IgG and FN quantitation 
(Dyaatech Laboratories Ltd., Sussex, Eng]and). The 96- and 24- 
well flat-bottomed plates, the 25 cm  z Roux flasks and the Tram- 
well chambers (catalog no. 3413; Costar Corp., Cambridge, MA) 
used for cell cultures, as well as the polystyrene Petri dishes used 
for the panning procedure and adherence separation were from 
Costar Corp. (Cambridge, MA). Recombinant human Ib6 was 
provided by Geazyme Corp. (Boston, MA). Gelatin and laminin 
were  purchased from  Sigma Chemical Co.  (St. Louis, MO). 
[3H]TdR with a specific activity of 5 Ci/mmol was purchased 
from Amersham International (Amersham, Bucks, UK). 
mAb against Adhesion Molecules.  Purified  and FITC-conjugated 
mAb IOP49e (anti-CD49e, VLA o~,), IOL44 (anti-CD44), and 
IOL54 (anti-CD54, ICAM1) were provided by Immunotech S.A. 
(Luminy, France). mAb BBA6 (anti-VCAM 1) was provided by 
British Bio-technology  Ltd. (Oxan, UK). mAb TS2/16 (anti-CD29, 
VLA 31), mAb HP2/1 and HPl/3 (anti-CD49d, VLA a~), mAb 
TP1/40 (anti-CDlla, LFA1),  and mAb TS2/7 (anti-CD49a, VLA 
~1) (13, 14) were the gift of Dr. F. S~nchez-Madrid  (Hospital de 
la Princesa, Madrid, Spain). mAb PlD6 (anti-CD49e, VLA c~s) 
(15) was the gift of Dr. E. Wyner (Cytel Corp., La Joila, CA). 
BMMC Preparation  and Purification.  BM cells  were obtained  from 
ribs removed  during thoracotomy from patients with localized  lung 
tumors. The patients were otherwise healthy. None had received 
steroids, cytostatic drugs, or radiotherapy, and their ages ranged 
from 34 to 58 yr. After cutting the ribs into pieces, BM cells were 
washed out by vigorous pipetting with HBSS, and were washed 
twice in the same medium.  BMMC were prepared by Ficoll- 
Hypaque density centrifugation. Fresh adherent BM ceils  were ob- 
tained after incubation of BMMC at 2  x  106 cells/ml on plastic 
petri dishes for 3 h, as previously reported (16). This population 
accounted for an average of 20% of the recovered ceils. The com- 
position of this freshly isolated BM adherent population has been 
previously reported (17), and consisted of mixed fibrobiasts, my- 
eloid ceils, macrophages, endothelial cells, and lymphoid cells. 
Nonadherent cells were further depleted of residual adherent ceils 
by magnetic removal of cells that phagocytosed carbonyl iron par- 
tides (18). Cytocentrifilgal  preparations of  unfractionated,  adherent, 
and nonadherent BM ceils were fixed in acetone, and the propor- 
tion of cells containing cytoplasmic Ig was estimated by a direct 
immunofluorescence  technique (D). BM nonadherent ceils  bearing 
and lacking VLA-4 and -5 molecules  on their surface  were obtained 
by treatment with specific  mAbs and immuno-magnetizable beads 
conjugated with goat anti-mouse Ig antibodies, as reported (20). 
In brief, nonadherent BM cells at 107 cell/ml were incubated with 
1 ~g of HP2/1 (anti-CD49d) or IOP49e (anti-CD49e) mAbs for 
30 rain at 4~  washed once, and incubated with goat anti-mouse 
Ig-coated beads (at a bead/cell ratio of  3:1) for 30 min at 40C. Cells 
were then diluted five times in cold PBS, and those which bound 
magnetizable beads were retained on the tube wall by a magnetic 
particle concentrator. Negative and positive calls for both markers 
were recovered, washed twice, and cultured. The efficiency  of the 
separation method was verified  by indirect  immunofluorescence  and 
flow cytometry  analysis  in an Epics Profile  cytometer  (Coulter Corp., 
Hialeah, FL). VLA-4  § and -5 + populations contained more than 
90% positive ceils for the corresponding marker, whereas <5% 
positive ceils were present in the negatively selected cell fractions 
VLA-4-  and VLA-5-. 
In some  experiments, BM cells capable of spontaneous Ig secre- 
tion were purified. To this end, adherent BM cells were removed 
as indicated above, and the nonadherent ceils were then depleted 
ofT lymphocytes  by a previously  described rosette technique (21). 
Non-T nonadherent BM calls were further fractionated according 
to the presence of CD38 molecules on their membrane by a previ- 
ously described panning technique (9). Positively  selected popula- 
tions (CD38 +) commonly exhibited more than 85% positive ceils 
for the CD38 marker and will be referred to as BM CD38 + cells. 
Spontaneous Ig-secreting cells were enriched in the purified BM 
CD38 § population by an average of five times (9). 
FN and FN Fragments.  Human plasma FN was the generous 
gift ofDrs. R Horowitz and R. Shulman  (New York Blood Center, 
New York). FN fragments  of  80 and 38 kD we~ prepared by trypsin 
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(22, 23). The 80-kD fragment contains the RGDS sequence (23), 
and the 38 kD fragment contains the entire HepII domain and 
most of the IIICS region of  FN, including the CS-1 sequence  (22). 
ECM proteins including FN, FN fragments, gelatin, and laminin 
were assessed in soluble as well as in fixed forms, as indicated. To 
obtain this htter form, microtiter culture wells  were incubated  with 
the proteins at indicated concentrations in 100/~1 of PBS for 2 h 
at room temperature, followed  by extensive  washing with PBS and 
a new incubation with 1% BSA-PBS. The plates were used the 
same day. 
Preparation  of  Stromal Cells  Derived  from LTBMC.  Stromal cells 
were derived from LTBMC, according to the technique described 
by Kierney and Dorshkind (24). Briefly, 5 ml of a suspension of 
fresh BMMC at 2  x  106 cells/m1 were cultured in 25 cm  z Koux 
flasks, in a culture medium containing 20% FCS, and half of the 
supernatant (SN) was replaced  weekly  with fresh medium. To elim- 
inate the remaining hematopoietic cells, all of the medium was re- 
moved after 2 wk, and the cells were cultured in fresh medium 
containing mycophenolic acid (MPA) at 5/zg/ml for 3 d. After 
this period, the cells  were again incubated in fresh medium without 
MPA. This treatment was repeated  on days  20 and 28. Subsequently, 
the cultures were continued by weekly replacement of half of the 
medium with fresh medium. At confluence, cultures were trip- 
sinized and subcultured as needed. Stromal cells maintained for 
60-120 days  were used in this work. After 60 d of  culture, LTBMC- 
derived stromal cells exhibited the appearance and phenotype of 
fibrobhsts (12). 
Cell Culture  BMMC and BM cell fractions obtained by mag- 
netic selection techniques were cultured at a concentration of 106 
cells/m1. Adherent and nonadherent BM cells were cultured at 0.2 
x  106 cells/m1  and at 0.8  x  106 cells/m1, respectively.  All the cul- 
tures were set up in 96-well fiat-bottomed plates in a final vol of 
0.25 ml for 14 d, unless otherwise indicated. The cultures were 
incubated at 37~  with 5% CO2 in a culture medium consisting 
of  ILPM11640 supplemented  with 10% FCS, L-glutamine  (10 raM) 
and gentamycin (0.05 mg/ml). The serum-free medium used in 
this work was identical, except for the substitution of a supple- 
ment consisting of transferrin (5 #g/m1), insulin (5/~g/~ul), and 
sodium selenite  (5 ng/ml) for FCS. At the end of the culture period, 
cell-free supematants were obtained by centrifugation and were 
stored at  -20~  until ELISA testing. DNA synthesis, measured 
as [3H]TdR-uptake, was evaluated in certain cultures by pulsing 
them with 1 #Ci of [3H]TdR. during the last 16 h of culture. Cells 
were then harvested onto glass fiber falters and counted by liquid 
scintillation spectrometry. To obtain conditioned SN from BM 
stromal cells, freshly  isohted (2  x  105 cells/ml), as well  as LTBMC- 
derived (2  x  104 cells/ml) adherent cells were cultured, and the 
culture media were recovered after 3 d and frozen until use. 
Solid Phase ELISA for IgG, 11.,6, and FN Determination.  The 
quantitative ELISA  used to measure the IgG secreted into the cul- 
ture SN was performed in microtiter plates, as described by de h 
Concha et al. (25). IL-6 was also determined in the same SN by 
using  an ELISA technique (InterTest-6  'm ELISA kit, Genzyme 
Corp., Boston,/VIA). FN present in culture supematants was de- 
termined by a sandwich ELISA  in microtiter plates, as follows: (a) 
wells were coated with 400 ng of anti-FN mAb in 200/zl of PBS 
for 16 h at room temperature; (b) free binding sites were blocked 
by incubating the wells with 1% BSA-PBS for 1 h; (c) purified 
FN and suitably diluted culture supernatants were incubated for 
2 h; (d) 200/~1  of  polydonal  rabbit anti-human FN antibodies  diluted 
in 1% BSA-PBS at 1/4,000 were added to each well and incubated 
for 2 h; and (e) finally, the wells were incubated with peroxidase- 
conjugated goat anti-rabbit  Ig antibodies at 1/1,000 dilution in 
1% BSA-PBS for 30 min, and revealed  with ot-phenylendiamine. 
The standard curve for FN was linear in the range of 2-50  ng. 
Results 
BM High Rate IgG-secreting Cells Require the Cooperation 
ofBM Stromal Cells.  We have previously reported that the 
majority of the BM cells capable of spontaneous and high 
rate Ig secretion are not totally differentiated when isolated 
from the body, but that they still require the presence of in- 
ductive factor(s) provided by adherent BM stromal cells. Ib6 
was identified as such a factor (12). Fig. 1 summarizes these 
observations: Fig. 1 A shows that unstimulated BMMC cul- 
tures produced IgG in a linear fashion over 2 wk; adherent 
BM cells  did not  secrete  any IgG;  nonadherent BM cells 
showed a low and short-term curve of IgG production, in 
spite of the fact that Ig-seereting cells, determined either as 
CD38+~g  ht cells or as calls containing cytoplasmic Ig, were 
retained in this cell fraction; the cocuhure of the two latter 
populations restored IgG secretion to the level of  unfraction- 
ated BMMC, and this effect could be reversed by the addi- 
tion of blocking anti-Ib6 antibodies. Fig. 1 B shows that 
the BM adherent cells were responsible for the endogenous 
Ib6 synthesis in these cultures. A similar ID6-mediated effect 
was obtained when either nonadherent BM cells or purified 
CD38 § cells were cocultured with LTBMC-derived fibro- 
blasts (12, and data not shown). Despite the important role 
demonstrated for Ib6 in this culture system, Hg. 2 shows 
that the cytokine alone was incapable of inducing IgG secre- 
tion in BM cells depleted of adherent cells, suggesting that 
additional signals provided by BM adherent stromal cells were 
needed for the high rate Ig secretion by BM cells to occur. 
Nature  of the  Signals Derived from  BM  Stromal Cells. 
Subsequently,  the possible requirement for signal(s) conveyed 
Figure 1.  Role  d ID6 and BM adherent  cells  in spontaneous  IgG um'e- 
aon by c~ln~t BMMC. (.4) BMIVtC  (10  6  cdh/ml), ~lh~t (ADH~.) 
BM cells (0.2 x  10  6 cells/ml), nonadherent  (NON-ADHER.) BM cells 
(0.8  x  10  6 cells/ml), and a combination  of the two latter populations, 
were cultured,  and the IgG secreted to the supermtant at different  times 
was mezsu_~l. Anti-IL-6 mAb was added to certain cultures at a final di- 
lution of 1/2,500. Results  of one of four simil~  experiments are shown, 
and represent the mean  of duplicate  cultures. (B) The production  of IL-6 
by the same  BM cell  popohtions  was determined  after  3 d of  culture. Results 
represent the mean _+  SEM of five experiments. 
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cells. BMMC and nonadherent  (NON-ADHER.) BM cells  were  cultured 
for 14 d and the IgG secreted  to the supernatants was determined. Ib6 
(1 ng/ml) was added to indicated  cultures. Results represent  the mean _+ 
SEM of eight experiments. 
through direct contact between adherent BM stromal cells 
and and BM Ig-secreting cells was investigated in two different 
approaches. First, since the adhesion molecules are involved 
in many examples of processes mediated by cell to cell con- 
tact, the effect of adding mAb directed against such mole- 
cules was explored in BMMC cultures. As shown in Fig. 3, 
only mAb directed to the VLA-4 heterodimer (CD29 CD49d) 
markedly inhibited IgG secretion in these cultures. Secondly, 
BM stromal cells and nonadherent BM cells were cocultured 
either together (cellular contact present) or separated in the 
two chambers of a Transwell culture system (cellular contact 
prevented). Table 1 shows that separated and unseparated cocul- 
tures produced similar quantities of IgG, ruling out the neces- 
sity for close cellular interactions in the present system. This 
fact was confirmed by the observation that SN obtained from 
cultures of freshly isolated adherent BM cells, as well as of 
LTBMC-derived stromal cells, were capable of restoring IgG 
secretion by nonadherent BM cells (Fig. 4). These results in- 
dicated two apparently contradictory facts: the integrin mol- 
ecule VLA-4 seemed to be involved in the regulation of BM 
cells  capable of high rate IgG secretion; and the inductive 
role of stromal cells on BM high rate IgG-secreting cells was 
due to soluble factor(s) produced by the former cells. 
Table  1.  Requirement  for Cellular Contact in the Inductive 
Effect of BM Stromal Cells on BM IgG-secreting Cells 
Cellular contact 
Exp. no.  Present  Prevented 
1'  992*  960 
2*  400  336 
3  s  2,150  2,450 
4S  900  1,000 
* Results represent  the mean IgG production  (ng/ml) in duplicate  cultures. 
* 2 x  10  s freshly-isolated  BM adherent  cells were cocultured  with 8 x 
10  s BM nonadherent  cells  either together  (contact  present) or in the two 
separate chambers of a Transwell  culture  system (contact  prevented). 1-ml 
cultures were set up in 24-well plates for 14 d. 
S 2 x  104 LTBMC-derived  stromal cells  were cocultured  with 2 x  10  s 
BM CD38  + cells, as described above. 
The Inductive Effect of  BM Stromal Cells Is Mediated by 11-.6 
plus FN.  Recent reports have dearly demonstrated that the 
well-defined component of the serum and of ECM FN is 
a ligand for VLA-4 (26-28).  In addition, BM cells can se- 
crete FN (29). Therefore, the possibility that FN was involved 
in the regulation of BM high rate IgG-secreting ceils  was 
investigated. First, FN production by BM cells in the present 
system was tested using FCS-free cultures. Fig.  5 A  shows 
that freshly isolated BM adherent cells, as well as LTBMC- 
derived stromal cells spontaneously and actively produced large 
amounts of FN in 3-d cultures. BM nonadherent cells did 
not produce any FN. Kinetic studies revealed that an average 
of 70% of the FN secreted by adherent BM cells occurred 
in the first 4 h of culture (data not shown). Moreover, Fig. 
5 B shows that the addition of anti-FN antibodies to BMMC 
cultures drastically reduced their subsequent IgG secretion, 
and this effect could be reversed by exogenous FN. The inhi- 
~  NON-ADHER. 
NON-ADHER.+SN  OF ADHER. 
NON-ADHER.+SN  OF  LTBMC 
I  BMMC 
Figure 3.  Effect  of the addition of mAb directed  to a variety  of adhe- 
sion molecules.  BMMC  were  cultured  for 14 d in the presence  and absence 
of a concentration  of 2/~g/ml of indicated mAbs, and the IgG secretion 
was determined. The values  were expressed  as a percentage  of untreated 
control  cukuses. Results  represent  the mean + SEM of  seven  experiments. 
Control IgG secretion in these experiments was 712  -+  187 ng/ml. 
i  i  i  J 
0  250  500  750 
Ig(3 PRODUCTION (ng/ml) 
Figure 4.  Effect  on BM IgG-secreting  cells of the conditioned  SN ob- 
tained from  cultures  of  adherent  BM cells. BMMC and nonadherent  (NON- 
ADHER.)  BM ceils were cultured for 14 d in the presence  and absence 
of 50% SN obtained  from cultures of freshly  isolated BM adherent  cells 
(SN OF ADHER.) and LTBMC-derived  fibroblasts, and the secreted  IgG 
was evaluated. Results represent  the mean -+ SEM of eight experiments. 
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of BM Cells Capable of High Rate IgG Secretion 
IgG secretion 
Unseparated 
Exp. no.  cells*  VLA-4  +  VLA-4-  VLA-5  +  VLA-5- 
ng/ml 
1  370*  530  42  <5  320 
2  720  880  30  <5  1,040 
Figure 5.  Role  of FN on BM spontaneous  IgG-secreting  cells. (A) FN 
secretion by BM cells. BMMC, adherent (ADHER.) and nonadherent 
(NON-ADHER.) BM cells, and LTBMC-derived  fibroblasts  were  cultured 
for three  days  in serum-free  medium,  and the quantity  of FN released to 
the superuatant  was determined  by ELISA.  Cycloheximide  (Cx; 10 #g/ml) 
was added  to certain  cultures.  Results  represent the mean _+ SEM of four 
experiments. (/3) BMMC  were cultured for 14 d in the presence and ab- 
sence of FN (15 #g/ml) and of anti-FN polyclonal  Ab at a dilution of 
1/50, and IgG secretion  was measured. (C) Nonadherent  BM cells were 
cultured either in FCS-containing  (FCS  +  ;filled boxes) or serum-free 
(FCS- ; open boxes)  medium  for 14 d in the presence and absence of Ib6 
(1 ng/ml), FN (15 #g/ml), and hydroxyurea  (OH-U; 0.5 mM), and the 
IgG secreted to the superuatant  was evaluated.  Values were expressed as 
a percentage  of control  lgG secretion.  Results  represent the mean _+ SEM 
of nine  and seven  experiments  for B and C, respectively.  The control  IgG 
production in the corresponding  experiments  was 547 •  213 ng/ml, and 
937  •  358 ng/ml for B and C, respectively. 
bition mediated by anti-FN antibodies was concentration de- 
pendent, and the effect reached a plateau at  1/50 dilution 
of the antibody, sparing some 10-20% of the IgG secretion. 
Taken together, these observations strongly suggested that, 
in addition to IL-6, the endogenous generation of FN by BM 
stromal cells might be important in the regulation of BM 
high rate IgG-secreting cells. Therefore, the effect of adding 
exogenous FN on cultures of nonadherent BM cells was as- 
sessed. As shown in Fig. 5 C, neither optimal quantities of 
IL-6 (1 ng/ml), nor FN used at 0.1-100  #g/ml (only data 
of adding 15 #g/ml of FN are  shown) was capable  of in- 
ducing IgG secretion in nonadherent BM cell cultures by it- 
self. The combination of  both factors, however, restored com- 
plete IgG production. This effect was similarly observed  in 
the presence  (filled boxes) and absence  (open boxes) of FCS, 
clearly indicating that the FN present in the FCS did not 
act in the system. The addition of FN in either soluble or 
fixed form was efficient  in inducing optimal IgG secretion 
in cultures of nonadherent BM cells supplemented with Ib6. 
This FN-mediated induction was concentration dependent, 
and the effect reached a plateau at 5 #g/cm  2 and 15 #g/ml 
for the fixed and soluble form, respectively. Neither laminin 
nor gelatin used in a wide range of  concentrations was capable 
of restoring the IgG secretion in similar cultures. It should 
also be noted in Fig.  5 C  that the inductive effect of IL-6 
* Unseparated cells and cell fractions  of BM nonadherent  cells were cul- 
tured at 106 cells/ml  for 14 d. IL-6  (1 ng/ml) and FN (15 #g/ml) were 
added to all cultures. No attempt  was made to detach the magnetic  beads 
from the cell surface in the positive fractions; however, the separation 
procedure did not seem to affect IgG secretion. 
*  Results represent the mean of duplicate cultures. 
plus FN on IgG secretion was not altered by the addition 
of the DNA synthesis inhibitor hydroxyurea (OH-U), used 
at a concentration capable of reducing over 90% of the PHA- 
induced proliferative response by blood lymphocytes. In line 
with this latter observation, the addition of IL-6 plus FN 
to these cultures did not induce DNA synthesis, detected as 
[3H]TdR-uptake.  Furthermore, the inductive effect of BM 
stromal cell SN on IgG secretion by nonadherent BM cells 
was equally inhibited by the addition of either anti-FN or 
anti-IL-6 antibodies. The inhibition mediated by these anti- 
bodies could be reversed by adding exogenous FN and IL-6, 
respectively (data not shown). 
BM Cells Capable of  Spontaneous and High Rate IgG Secre- 
tion Exhibit the FN Receptor VLA-4.  To further substantiate 
the involvement of FN in the induction of Ig secretion by 
the BM cell subset under study, the expression  of the two 
well-known FN receptors  VLA-4 and -5 (26-28, 30, 31) on 
these cells was examined. First, BM cells were labeled for 
the CD38 antigen (OKT 10-PE mAb) and for either VLA-4 
(HP2/1 mAb-FITC) or -5 (IOP49e mAb-FITC) molecules, 
and flow cytometry  analysis showed that all the cells expressing 
high  levels of  CD38  antigens,  which  include  the  BM- 
spontaneous Ig-secreting cells (9), also coexpressed high levels 
of VLA-4, but not -5 molecules (data not shown). To confirm 
this finding, nonadherent BM cells were separated into posi- 
tive and negative cell fractions for these latter markers, and 
the IgG secretion by unseparated and different separated cell 
fractions (VLA-4 +,  VLA-4-,  VLA-5 +,  and VLA-5-) was 
evaluated  after 14 d of culture in the presence  of IL-6 plus 
FN. The results contained in Table 2 indicated that BM IgG- 
secreting cells showed the phenotype VLA-4 + VLA-5-. 
VLA-4-FN Interaction Is Essential  for the Function of BM 
Cells Capable of High Rate Ig Secretion.  The above results 
suggested that the interaction of  FN with the cellular receptor 
VLA-4 was involved in the regulation of BM cell Ig secre- 
tion. To confirm this, the effect of FN on the inhibition of 
IgG secretion mediated by anti-VLA-4 mAb (Fig. 3) was ex- 
amined. Fig. 6 A  shows that the inhibitory effect of HP2/1 
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cells. (A) BMMC were cultured for 14 d in the presence and absence of 
anti-CD49d mAb HP2/1 (2/~g/ml) and FN (15 gg/ml), and the IgG 
secreted to the SN was measured. (B) Similar cultures were set up in the 
presence and absence of 2/tg/ml of the indicated anti-CD49d mAbs, and 
the IgG secretion was determined. (C) Nonadherent BM ceils were cul- 
tured in the presence and absence of Ib6 (1 ng/ml), FN (5/~g/cm2), 80 
kD FN fragment  (80FN;  5 /~g/crnZ), 38 kD  FN fragment  (38FN;  5 
gg/cmZ), anti-CD49d mAb HP2/1 (aVLA4; 2 #g/ml), and anti-CD49e 
mAb PlD6 (aVLAS; 2/~g/ml), and IgG secreted to the SN was evaluated. 
Values were expressed as a percentage of the control IgG production in 
untreated BMMC cultures. Results are e~pressed as the mean •  SEM. 
of five, four, and four experiments for A, B, and C, respectively. Control 
IgG secretion in these experiments was 460  •  156, 725  •  232, and 812 
•  380 ng/ml for A, 13, and C, respectively. 
(anti-CD49d) mAb on BMMC IgG secretion could be reversed 
by the addition of exogenous FN. Furthermore, as shown 
in Fig. 6 B, the inhibitory effect of anti-CD49d mAb was 
only observed with the mAb HP2/1, which has been shown 
to block the FN-binding site of VLA-4 molecules, but not 
with the mAb HP1/3, which does not interfere with FN 
VLA-4 recognition (32). 
To establish the specifidty of this FN-mediated phenomenon 
more dearly, two different fragments of the FN molecule 
were prepared, one of 38 kD containing the CS-1 region, 
and another of 80 kD comprising the RGDS sequence (22, 
23), and their inductive effects on IgG secretion by nonad- 
herent BM cells were evaluated. As shown in Fig. 6 C, the 
38-kD fragment fully restored IgG secretion by IL-6-sup- 
plemented nonadherent BM cell cultures. This effect could 
be inhibited by anti-VLA-4 mAb, but not by anti-VLA-5 mAb. 
In contrast, the 80-kD fragment exerted no effect. 
Similar results were found when IgA and IgM were evalu- 
ated in these cultures (data  not shown). 
Discussion 
It is now well established that the marrow microenviron- 
ment plays an essential role in the ontogenic development 
of many cell types, including lymphocytes (33, 34). Evidence 
accumulated in recent years has greatly increased our knowl- 
edge about the cellular and molecular mechanisms  by which 
this supportive effect of BM is accomplished. Thus, a variety 
of BM stromal cells capable of producing cytokines and ECM 
proteins have  been involved in many aspects  of  BM hem.  opoiesis 
(35).  Despite the fact that the majority of B lymphocytes 
capable of high rate Ig secretion are located in this organ (1, 
2), little is known about their interaction with marrow cells. 
Namely, it remains to be ducidated whether the BM is a 
storage organ for B lymphocytes that have reached flail matu- 
rity, or whether it influences the terminal differentiation of 
the Ig-secreting cells. 
Human BM cells capable of spontaneous and high rate Ig 
secretion in vitro appear to be a relevant model for analyzing 
the regulation of final B cell maturation in the BM.  It has 
been previously shown that IL-6 production by BM stromal 
cells was required for most of the Ig secretion occurring in 
this system, and this suggested a regulatory role for cells of 
the marrow microenvironment (12). Present resttlts indicate 
that an additional factor synthesized by BM stromal cells was 
also needed, since exogenous Ib6 was unable to induce Ig 
secretion in  the  absence  of adherent BM  cells. This was 
confirmed by the finding that BM stromal cell SN restored 
Ig  secretion by  nonadherent  BM  cell  cultures.  FN  was 
identified as this additional factor,  as can be deduced from 
the following observations:  (a) as previously reported (29), 
and also demonstrated here, BM stromal cells constitutively 
produced FN; (b) anti-FN antibodies markedly reduced the 
IgG secretion in BMMC cultures and blocked the inductive 
effect of stromal cell SN on nonadherent BM cells, and this 
blockade could be reversed by exogenous FN; and (c) finally, 
although neither IL-6 nor FN alone exerted  any effect, the 
combination of both factors induced optimal Ig secretion by 
BM nonadherent cells. These findings demonstrate that FN 
and IL-6 each alone were necessary, but not std~cient, factors, 
and that the coordinated activity of both was required for 
optimal induction of BM high rate Ig-secreting cells. Since 
FN rapidly adheres onto culture surfaces, the experiments 
described above did not clarify whether this ECM molecule 
might act in a soluble nonfixed form in the present system. 
In contrast to the well-established  role of Ib6 as a B cell 
differentiation factor (36-39),  FN had not been clearly related 
to this activity. 
It should be noted that a minor part of BMMC sponta- 
neous Ig secretion seemed to be independent of Ib6 and FN, 
since 10-25%  of this activity remained in the presence  of 
saturating quantities of anti-IL-6 (12) and anti-FN blocking 
antibodies.  This might reflect the existence of cells that had 
already received the inductive signal in vivo. 
Three different FN receptors have been identified in the 
VIA family ofintegrins: VLA-3 (CD29 CA9c), VLA-4 (CD29 
CD49d),  and VLA-5  (CD29 CD49e) (23,  26-28,  30, 31). 
VLA-3 is mainly expressed on most adherent cells, and binds 
FN at an undetermined site (40). VLA-4 and -5 are widely 
expressed in the lymphoid system (41). VLA-5 recognizes the 
KGDS sequence located in the central region of all FN mole- 
cules (30,  31). VLA-4 binds to the CS-1 region present in 
FN molecules containing the alternatively  spliced segment 
1744  VLA-4-fibronectin  Interaction Regulates Final B Cell Maturation known as IIICS domain (26-28). Present data strongly sug- 
gest that VLA-4 molecules function as FN receptors in this 
system. This is based on the following facts: (a) mAbs directed 
to CD29 and CD49d, but not those directed to other adhe- 
sion molecules, inhibited Ig secretion in BMMC cultures, 
and this effect was reversed by FN; (b) the inductive role of 
the entire FN molecule could be replaced by a fragment con- 
taining the CS-1 region, but not by a fragment containing 
the KGDS sequence; and (c) only mAbs anti-CD49d capable 
of blocking VLA-4 FN interaction 0 2) inhibited induction 
by either FN or the CS-l-containing fragment of FN. There- 
fore, VLA-4 FN interaction plays a critical role in the present 
culture system, and, along with ID6, appears to fidfill all the 
signaling requirements for induction of high rate Ig secre- 
tion by BM cells. 
FN contained in the FCS was found to be ineffident in 
restoring Ig secretion by nonadherent BM cell cultures sup- 
plernented with IL-6. The reason for this is unknown. An 
explanation could be the reported structural differences,  notably 
in carbohydrate contents, between phsma and fetal (placental) 
FN (42, 43), which may somehow affect the interaction with 
the cell surface. 
Interactions between cells and ECM components seem to 
control important biological processes such as cell migration, 
embryogenesis, tumor metastasis, and wound healing. Spe- 
cifically, FN-VLA-4 interaction has been implicated in the 
promotion of cell anchorage and migration of hematopoietic 
precursors, activated  B  and T  lymphocytes, and NK cells 
(44--47), and in the proliferation of T cells (48-50). FN has 
also been demonstrated to supply differentiation signals in 
several cell systems (44, 51-54), and VLA-4 appeared t~ be 
the cellular FN receptor in some of these instances (44, 54). 
Data in the present paper indicate that the inductive effect 
of FN plus IL-6 on BM Ig-secreting cells occurred in the ap- 
parent absence of call growth, since DNA synthesis was not 
detectable in these cultures and Ig secretion was not affected 
by DNA synthesis inhibition. Therefore, IL-6  plus FN conveys 
a differentiation signal upon the receival of which the BM 
producers  proceed  into  the  prolonged  and  high  rate  Ig-secreting 
stage  characteristic  of these  cells. 
The mechanism(s) by which this maturative event is trig- 
gered by IL-6 plus FN is unknown. The finding that BM 
Ig-secreting ceils exhibited VLA-4 molecules, and that the 
requirement for VLA-4-FN recognition was evidenced in BM 
CD 38 + cell cultures supports the view that this latter in- 
teraction takes place on the surface of the secreting cell. In 
addition, the fact that neither of the two factors has any effect 
alone could indicate that IL-6 plus FN delivers an integral 
signal to these cells, perhaps in a manner similar to what 
has been proposed for fibroblast growth regulation by basic 
fibroblast  growth factor, cellular and ECM heparan-sulfate, 
and the polypeptidic cellular  receptor (55). 
B cell differentiation has been traditionally understood as 
a T cell-dependent event. The present subset of Ig-secreting 
cells, which probably represents a relevant  stage in the se- 
quence of B cell differentiation in vivo, seemed to undergo 
te~i~inal maturation under the influence of cells of the marrow 
microenvironment and their products. This observation sug- 
gests that in vivo differentiation of high rate Ig-secreting lym- 
phocytes within the BM could be primarily mediated by 
stromal cells rather than by T cells. Such a notion is compat- 
ible with the in vivo pattern of homing and distribution of 
plasmabhsts and plasma cells in the BM, since they are mostly 
found at the adventitial space of the BM arterial capillaries, 
juxtaposed to the FN-rich vascular basal membrane, in close 
vicinity to stromal, but not T cells (56, and data not shown). 
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